AngioDynamics, Inc. - צמיחת מכירות משנה לשנה (TTM) ANGO

AngioDynamics, Inc. (ANGO) collaboration with oncology centers to develop minimally invasive systems sets a positive trajectory. The YoY revenue growth trend for TTM confirms this momentum, with the metric standing at 8.10. Stable demand for angiography equipment supports the business, although global trade restrictions and challenges with Asian electronics may hinder the manufacturer's international expansion.
AngioDynamics, Inc. - פילוחים אנליטיים ומדדי מפתח (ANGO)

The steady confidence of surgeons in AngioDynamics, Inc. (ANGO) minimally invasive instruments is reflected in the TTM revenue growth rates compared to last year, confirming the success of the asset portfolio transformation. This indicator captures the relative change in annual turnover over the last twelve months, allowing investors to assess real business expansion and timely identify the risk of overpaying for shares should market demand decelerate.